European Union Medical Device Regulation (MDR)

The Medical Device Regulation (EU) 2017/745 (MDR) is the current legislative framework governing the safety, performance, and clinical evaluation of medical devices in the European Union. It replaced the older Medical Device Directive (MDD) to better account for technological advancements and improve patient safety.

1. Key Regulatory Bodies and Their Roles

The European regulatory system is decentralized, involving several key entities:

• European Commission (EC): Oversees the implementation of the MDR across the EU and manages EUDAMED (the European database on medical devices).
• Competent Authorities (CAs): National regulatory bodies in each EU member state (e.g., BfArM in Germany, ANSM in France) that enforce the MDR, monitor clinical trials, and conduct market surveillance.
• Notified Bodies (NBs): Independent third-party organizations designated by member states to assess the conformity of medium and high-risk devices before they can be CE-marked and sold.

2. Device Classification

Devices are classified based on their intended purpose and inherent risks:

• Class I: Low risk (e.g., stethoscopes, corrective glasses).
• Class IIa: Low-medium risk (e.g., hearing aids, syringes).
• Class IIb: Medium-high risk (e.g., ventilators, infusion pumps).
• Class III: High risk (e.g., pacemakers, heart valves, neurological implants).

3. Core Requirements under MDR

• Technical Documentation: Manufacturers must maintain extensive technical files demonstrating safety and performance.
• Clinical Evaluation: A continuous process to collect and analyze clinical data to verify the clinical safety and performance of the device.
• Unique Device Identification (UDI): A system that enables easier tracking and traceability of devices throughout the supply chain.
• Post-Market Surveillance (PMS): Mandatory systems for manufacturers to monitor their devices' performance once they are on the market and report serious incidents.